Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556787 · ClinicalTrials.gov registry record · NA
An Evaluation of a Gender Specific Insole to Provide Relief From Knee Pain Due to Osteoarthritis or General Anterior Knee Pain in Male Subjects When Used in Foot Wear Over a Period of Four Weeks
A NA study of Osteoarthritis, Knee, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
- 2
- Study locations
NCT03556787: Completed NA study of Osteoarthritis, Knee, sponsored by Bayer.
NCT03556787 is a NA study of Osteoarthritis, Knee that has completed, run by Bayer. The registered enrollment target is 89 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03556787, a NA study of Osteoarthritis, Knee, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this trial is to demonstrate the ability of a full length foam insole to provide relief from pain due to osteoarthritis of the knee or general knee pain when used in foot wear for a 4-week period of time. The secondary objectives comprise the evaluation of the insole's ability to provide appropriate shoe fit and comfort as well as relief from osteoarthritis/ general knee pain after short-term use. The safety and tolerability of the test articles in terms of adverse events (AE) will also be investigated.
Primary Outcome
100 mm Visual Analog Scale: 0 = no pain to 100 = worst pain possible
Conditions Studied
Interventions
- DEVICE BPI 1000013 (Dr Scholls Insole)
Study Locations (2)
California
- Focus & Testing, Inc. - Calabasas
Ohio
- The Wolf Group - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2018-11-08 |
| Phase | NA |
What the finished NCT03556787 record still lists
NCT03556787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which BPI 1000013 (Dr Scholls Insole) is the first listed.
NCT03556787 reports a single indexed study location in California, Ohio.
Frequently Asked Questions
What is clinical trial NCT03556787 about?
NCT03556787 is a clinical study titled "An Evaluation of a Gender Specific Insole to Provide Relief From Knee Pain Due to Osteoarthritis or General Anterior Knee Pain in Male Subjects When Used in Foot Wear Over a Period of Four Weeks". The primary objective of this trial is to demonstrate the ability of a full length foam insole to provide relief from pain due to osteoarthritis of the knee or general knee pain when used in foot wear for a 4-week period of time. The secondary objectives comprise the evaluation of the insole's abil...
What is the current status of trial NCT03556787?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2018-06-04. Estimated completion is 2018-11-08.
What conditions does trial NCT03556787 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT03556787?
The interventions under investigation include: BPI 1000013 (Dr Scholls Insole) (DEVICE).
Who is sponsoring clinical trial NCT03556787?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03556787 being conducted?
This trial has 2 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03556787's enrollment target sits among peer trials
89 71st of 112 higher than 41 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobilizing Hispanics With Knee Osteoarthritis
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
The Osteoarthritis Prevention Study
RECRUITING · NA
-
Navio Robotic Versus Conventional Total Knee Arthroplasty
RECRUITING · NA
-
MOTION Clinical Trial
RECRUITING · NA
-
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI